Form D Explorer
60 DEGREES PHARMACEUTICALS, INC. · CIK 1946563

Citable research briefCompare issuerPrivate research collection

60 DEGREES PHARMACEUTICALS, INC.

CIK 1946563 · Corporation · Inc. DELAWARE · WASHINGTON, DC · Pharmaceuticals
Sign up to follow
Filings
2
Original notices
2
Amendments
0
Activity
Feb 11, 2025
through Feb 12, 2025

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldFeb 11, 2025 · DFeb 12, 2025 · DLater minus earlier
Reported offering amount$1,043,002$1,075,003$32,001
Reported amount sold$1,043,002$1,075,003$32,001
Reported investor count———
Reported minimum investment$0$0$0

Earlier SEC source: 0001946563-25-000001 · Later SEC source: 0001946563-25-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot

Form D · Feb 12, 2025

Reported offering amount
$1,075,003
Reported amount sold
$1,075,003

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Contact info

Log in to look up an email or website for this issuer.

Form D filings (2)